IRIS Accounts Production v24.2.0.383 07482655 Board of Directors 1.2.23 31.1.24 31.1.24 false true false false true false Ordinary 1.00000 Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh074826552023-01-31074826552024-01-31074826552023-02-012024-01-31074826552022-01-31074826552022-02-012023-01-31074826552023-01-3107482655ns15:EnglandWales2023-02-012024-01-3107482655ns14:PoundSterling2023-02-012024-01-3107482655ns10:Director12023-02-012024-01-3107482655ns10:PrivateLimitedCompanyLtd2023-02-012024-01-3107482655ns10:SmallEntities2023-02-012024-01-3107482655ns10:AuditExemptWithAccountantsReport2023-02-012024-01-3107482655ns10:SmallCompaniesRegimeForDirectorsReport2023-02-012024-01-3107482655ns10:SmallCompaniesRegimeForAccounts2023-02-012024-01-3107482655ns10:FullAccounts2023-02-012024-01-3107482655ns10:OrdinaryShareClass12023-02-012024-01-3107482655ns10:Director22023-02-012024-01-3107482655ns10:RegisteredOffice2023-02-012024-01-3107482655ns5:CurrentFinancialInstruments2024-01-3107482655ns5:CurrentFinancialInstruments2023-01-3107482655ns5:Non-currentFinancialInstruments2024-01-3107482655ns5:Non-currentFinancialInstruments2023-01-3107482655ns5:ShareCapital2024-01-3107482655ns5:ShareCapital2023-01-3107482655ns5:RetainedEarningsAccumulatedLosses2024-01-3107482655ns5:LeaseholdImprovements2023-01-3107482655ns5:PlantMachinery2023-01-3107482655ns5:FurnitureFittings2023-01-3107482655ns5:ComputerEquipment2023-01-3107482655ns5:LeaseholdImprovements2023-02-012024-01-3107482655ns5:PlantMachinery2023-02-012024-01-3107482655ns5:FurnitureFittings2023-02-012024-01-3107482655ns5:ComputerEquipment2023-02-012024-01-3107482655ns5:LeaseholdImprovements2024-01-3107482655ns5:PlantMachinery2024-01-3107482655ns5:FurnitureFittings2024-01-3107482655ns5:ComputerEquipment2024-01-3107482655ns5:LeaseholdImprovements2023-01-3107482655ns5:PlantMachinery2023-01-3107482655ns5:FurnitureFittings2023-01-3107482655ns5:ComputerEquipment2023-01-3107482655ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2023-01-3107482655ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2023-02-012024-01-3107482655ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2024-01-3107482655ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2023-01-3107482655ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-01-3107482655ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-01-3107482655ns5:HirePurchaseContractsns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-01-3107482655ns5:HirePurchaseContractsns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-01-3107482655ns5:BetweenOneFiveYearsns5:HirePurchaseContracts2024-01-3107482655ns5:BetweenOneFiveYearsns5:HirePurchaseContracts2023-01-3107482655ns5:HirePurchaseContracts2024-01-3107482655ns5:HirePurchaseContracts2023-01-3107482655ns5:WithinOneYear2024-01-3107482655ns5:WithinOneYear2023-01-3107482655ns5:BetweenOneFiveYears2024-01-3107482655ns5:BetweenOneFiveYears2023-01-3107482655ns5:AllPeriods2024-01-3107482655ns5:AllPeriods2023-01-3107482655ns10:OrdinaryShareClass12024-01-31074826551ns10:Director12023-01-31074826551ns10:Director12022-01-31074826551ns10:Director12023-02-012024-01-31074826551ns10:Director12022-02-012023-01-31074826551ns10:Director12024-01-31074826551ns10:Director12023-01-3107482655ns10:Director222023-01-3107482655ns10:Director222022-01-3107482655ns10:Director222023-02-012024-01-3107482655ns10:Director222022-02-012023-01-3107482655ns10:Director222024-01-3107482655ns10:Director222023-01-31
REGISTERED NUMBER: 07482655 (England and Wales)









UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JANUARY 2024

FOR

EPIGENETICS LTD

EPIGENETICS LTD (REGISTERED NUMBER: 07482655)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2024










Page

Company Information 1

Accountants' Report 2

Balance Sheet 3 to 4

Notes to the Financial Statements 5 to 9


EPIGENETICS LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 31 JANUARY 2024







DIRECTORS: Mr C R Astill-Smith
Miss G J Farr





REGISTERED OFFICE: First Floor North
40 Oxford Road
High Wycombe
Buckinghamshire
HP11 2EE





REGISTERED NUMBER: 07482655 (England and Wales)





ACCOUNTANTS: Seymour Taylor Limited
First Floor North
40 Oxford Road
High Wycombe
Buckinghamshire
HP11 2EE

ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS
ON THE UNAUDITED FINANCIAL STATEMENTS OF
EPIGENETICS LTD


The following reproduces the text of the report prepared for the directors in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Directors are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Epigenetics Ltd for the year ended 31 January 2024 which comprise the Income Statement, Balance Sheet, Statement of Changes in Equity and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the Board of Directors of Epigenetics Ltd, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Epigenetics Ltd and state those matters that we have agreed to state to the Board of Directors of Epigenetics Ltd, as a body, in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Epigenetics Ltd and its Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that Epigenetics Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Epigenetics Ltd. You consider that Epigenetics Ltd is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Epigenetics Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






Seymour Taylor Limited
First Floor North
40 Oxford Road
High Wycombe
Buckinghamshire
HP11 2EE


1 October 2024

EPIGENETICS LTD (REGISTERED NUMBER: 07482655)

BALANCE SHEET
31 JANUARY 2024

2024 2023
as restated
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 165,590 173,848

CURRENT ASSETS
Stocks 381,796 271,301
Debtors 5 82,982 100,805
Cash at bank and in hand 141,187 87,850
605,965 459,956
CREDITORS
Amounts falling due within one year 6 322,117 270,974
NET CURRENT ASSETS 283,848 188,982
TOTAL ASSETS LESS CURRENT
LIABILITIES

449,438

362,830

CREDITORS
Amounts falling due after more than one
year

7

(28,009

)

(44,087

)

PROVISIONS FOR LIABILITIES (41,498 ) (46,508 )
NET ASSETS 379,931 272,235

CAPITAL AND RESERVES
Called up share capital 9 100 100
Retained earnings 379,831 272,135
SHAREHOLDERS' FUNDS 379,931 272,235

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

EPIGENETICS LTD (REGISTERED NUMBER: 07482655)

BALANCE SHEET - continued
31 JANUARY 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 1 October 2024 and were signed on its behalf by:





Mr C R Astill-Smith - Director


EPIGENETICS LTD (REGISTERED NUMBER: 07482655)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2024


1. STATUTORY INFORMATION

Epigenetics Ltd is a private company limited by shares and incorporated in England and Wales. The address of the company's registered office is First Floor North, 40 Oxford Road,, High Wycombe, Buckinghamshire, HP11 2EE. The registered number is 07482655.

The presentation currency of these financial statements is Sterling (£), being the currency of the primary economic market in which the entity operates (its functional currency). All amounts in these financial statements have been rounded to the nearest pound unless stated otherwise.

The significant accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all years presented unless otherwise stated.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimate useful life or, if held under a finance lease, over the lease term, whichever is the shorter.


Plant and machinery - reducing balance - 25%
Fixtures and fittings - reducing balance - 15%
Computer equipment - straight line - 33%
Leasehold Property Improvements - straight line over 6 years

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


EPIGENETICS LTD (REGISTERED NUMBER: 07482655)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2024


2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 29 (2023 - 29 ) .

4. TANGIBLE FIXED ASSETS
Improvements Fixtures
to Plant and and Computer
property machinery fittings equipment Totals
£    £    £    £    £   
COST
At 1 February 2023 142,763 300,167 23,779 66,130 532,839
Additions - 39,174 7,943 4,333 51,450
At 31 January 2024 142,763 339,341 31,722 70,463 584,289
DEPRECIATION
At 1 February 2023 121,816 162,076 15,222 59,877 358,991
Charge for year 6,620 44,317 2,475 6,296 59,708
At 31 January 2024 128,436 206,393 17,697 66,173 418,699
NET BOOK VALUE
At 31 January 2024 14,327 132,948 14,025 4,290 165,590
At 31 January 2023 20,947 138,091 8,557 6,253 173,848

EPIGENETICS LTD (REGISTERED NUMBER: 07482655)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2024


4. TANGIBLE FIXED ASSETS - continued

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:
Plant and
machinery
£   
COST
At 1 February 2023
and 31 January 2024 106,798
DEPRECIATION
At 1 February 2023 36,898
Charge for year 17,475
At 31 January 2024 54,373
NET BOOK VALUE
At 31 January 2024 52,425
At 31 January 2023 69,900

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
as restated
£    £   
Trade debtors - 1,345
Other debtors 82,982 99,460
82,982 100,805

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
as restated
£    £   
Bank loans and overdrafts 10,000 11,621
Hire purchase contracts (see note 8) 16,359 14,841
Trade creditors 118,030 131,244
Taxation and social security 119,490 66,391
Other creditors 58,238 46,877
322,117 270,974

EPIGENETICS LTD (REGISTERED NUMBER: 07482655)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2024


7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2024 2023
as restated
£    £   
Bank loans 13,333 23,333
Hire purchase contracts (see note 8) 14,676 20,754
28,009 44,087

8. LEASING AGREEMENTS

Minimum lease payments fall due as follows:

Hire purchase contracts
2024 2023
as restated
£    £   
Net obligations repayable:
Within one year 16,359 14,841
Between one and five years 14,676 20,754
31,035 35,595

Non-cancellable operating leases
2024 2023
as restated
£    £   
Within one year 3,097 6,406
Between one and five years - 5,697
3,097 12,103

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: as
restated
£    £   
100 Ordinary £1 100 100

EPIGENETICS LTD (REGISTERED NUMBER: 07482655)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2024


10. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 January 2024 and 31 January 2023:

2024 2023
as restated
£    £   
Mr C R Astill-Smith
Balance outstanding at start of year 24,460 2,517
Amounts advanced - 24,333
Amounts repaid (15,158 ) (2,390 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 9,302 24,460

Miss G J Farr
Balance outstanding at start of year 2,651 2,651
Amounts advanced 12,237 -
Amounts repaid (12,237 ) -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 2,651 2,651